Express News | Citius Pharmaceuticals Inc - Regains Compliance With Nasdaq Listing Rule 5550(a)(2)

BreakingsDec 21 05:32

Maxim Group Maintains Citius Pharmaceuticals(CTXR.US) With Buy Rating

Futu NewsNov 28 00:32 · Ratings

Promising Outlook for Citius Pharmaceuticals: Buy Rating Affirmed Amid Product Potential and Strategic Developments

TipRanksNov 28 00:25 · Ratings

Why Nutanix Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket

BenzingaNov 27 17:52

When Will Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Breakeven?

Simply Wall StNov 26 21:33

Citius Pharmaceuticals Reports Productive FDA Type C Meeting to Discuss Phase 3 Mino-Lok Program and Pathway to Approval

PR NewswireNov 25 21:03